Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;15(11):708-709.
doi: 10.11909/j.issn.1671-5411.2018.11.007.

Ivabradine tolerability in heart failure

Sarah Birkhoelzer  1 , Daniel Stevens  2 , Donah Zachariah  1 , Jackie Taylor  3 , Nigel Rowell  4 , Paul R Kalra  1
Affiliations

Ivabradine tolerability in heart failure

Sarah Birkhoelzer et al. J Geriatr Cardiol. 2018 Nov.
No abstract available

Keywords: Heart failure; Ivabradine; Quality of life; The elderly.

PubMed Disclaimer

References

    1. Swedberg K, Komajda M, SHIFT Investigators Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376:875–885. - PubMed
    1. Tavazzi L, Swedberg K. Efficacy and safety of ivabradine in chronic heart failure across the age spectrum: insights from the SHIFT study. Eur J Heart Fail. 2013;11:1296–1303. - PubMed
    1. Stewart Coats AJ. Heart rate as a target: Ready for pole position? Int J Cardiol. 2018;260:131–132. - PubMed
    1. Ponikowski P, Voors A, ESC Scientific Document Group 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Eur Heart J. 2016;37:2129–2200. - PubMed
    1. Zachariah D, Taylor J, Rowell R, et al. Drug therapy for heart failure in older patients—what do they want? J Geriatr Cardiol. 2015;12:165–173. - PMC - PubMed

LinkOut - more resources